amcinonide
Regulatory sources consulted
Approved indications
- Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Contraindications
Absolute
- Hypersensitivity to amcinonide or any component.
Clinical warnings
- Major warning · Use the smallest effective amount for the shortest possible time. Large areas, prolonged use, an impaired skin barrier, and occlusion increase absorption and may cause reversible HPA-axis suppression, Cushing syndrome, hyperglycemia, or glucosuria; children are more susceptible. — DailyMed/openFDA, SPL set ID 83da75e7-e182-4a6c-ac0f-50d99971ebde
- Avoid eye contact. Stop if irritation or sensitization occurs. Treat any skin infection; if it does not respond promptly, stop the corticosteroid until it is controlled. — DailyMed/openFDA, SPL set ID 83da75e7-e182-4a6c-ac0f-50d99971ebde
Pregnancy and lactation
No specific recommendation is established during pregnancy. During breastfeeding, decide whether to stop breastfeeding or stop the medicine according to the importance of treatment for the mother.